Síndrome inflamatorio multisistémico de tipo Kawasaki asociado a COVID-19 en un adulto

Recently, few reports have described a serious condition linked to SARS-CoV-2 that mimics Kawasaki disease called Multisystem inflammatory syndrome, especially in children (MIS-C) and young adults. In this work, we report on a severe form of MIS in a young female adult previously infected by SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Elouardi, Y., Rebahi, H., Zarrouki, Y., Ziadi, A., Younous, S., Samkaoui, M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España, S.L.U. 2022
Materias:
Caso Clínico
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834333/
https://www.ncbi.nlm.nih.gov/pubmed/33994586
http://dx.doi.org/10.1016/j.redar.2020.11.013
Descripción
Sumario:Recently, few reports have described a serious condition linked to SARS-CoV-2 that mimics Kawasaki disease called Multisystem inflammatory syndrome, especially in children (MIS-C) and young adults. In this work, we report on a severe form of MIS in a young female adult previously infected by SARS-CoV-2. She was treated by plasmapheresis with albumin and steroids, however outcome was fatal. We discuss the pathogenesis of this rare and life threatening entity and suggest some therapeutic regimen. This syndrome should not be misdiagnosed with an infectious or a drug induced cutaneous rash in the current context of COVID-19 pandemic.

Ejemplares similares